Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Regional patterns of 18F-florbetaben uptake in presenilin 1 mutation carriers.

Sala-Llonch R, Falgàs N, Bosch B, Fernández-Villullas G, Balasa M, Antonell A, Perissinotti A, Pavía J, Campos F, Lladó A, Lomeña F, Sánchez-Valle R.

Neurobiol Aging. 2019 May 17;81:1-8. doi: 10.1016/j.neurobiolaging.2019.04.010. [Epub ahead of print]

PMID:
31207465
2.

Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment.

Falgàs N, Tort-Merino A, Balasa M, Borrego-Écija S, Castellví M, Olives J, Bosch B, Férnandez-Villullas G, Antonell A, Augé JM, Lomeña F, Perissinotti A, Bargalló N, Sánchez-Valle R, Lladó A.

Eur J Neurol. 2019 Feb 21. doi: 10.1111/ene.13945. [Epub ahead of print]

PMID:
30793432
3.

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.

Sánchez-Valle R, Heslegrave A, Foiani MS, Bosch B, Antonell A, Balasa M, Lladó A, Zetterberg H, Fox NC.

Alzheimers Res Ther. 2018 Nov 3;10(1):113. doi: 10.1186/s13195-018-0439-y.

4.

The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology.

Lladó A, Tort-Merino A, Sánchez-Valle R, Falgàs N, Balasa M, Bosch B, Castellví M, Olives J, Antonell A, Hornberger M.

Neurobiol Aging. 2018 Oct;70:1-9. doi: 10.1016/j.neurobiolaging.2018.05.035. Epub 2018 Jun 1.

PMID:
29935415
5.

Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.

Borrego-Écija S, Morgado J, Palencia-Madrid L, Grau-Rivera O, Reñé R, Hernández I, Almenar C, Balasa M, Antonell A, Molinuevo JL, Lladó A, Martínez de Pancorbo M, Gelpi E, Sánchez-Valle R.

Dement Geriatr Cogn Disord. 2017;44(3-4):213-221. doi: 10.1159/000480077. Epub 2017 Sep 22.

PMID:
28934750
6.

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.

Miller AM, Balasa M, Blennow K, Gardiner M, Rutkowska A, Scheltens P, Teunissen CE, Visser PJ, Winblad B, Waldemar G, Lawlor B.

J Alzheimers Dis. 2017;60(1):201-210. doi: 10.3233/JAD-170502.

PMID:
28826189
7.

Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.

Carmona-Iragui M, Balasa M, Benejam B, Alcolea D, Fernández S, Videla L, Sala I, Sánchez-Saudinós MB, Morenas-Rodriguez E, Ribosa-Nogué R, Illán-Gala I, Gonzalez-Ortiz S, Clarimón J, Schmitt F, Powell DK, Bosch B, Lladó A, Rafii MS, Head E, Molinuevo JL, Blesa R, Videla S, Lleó A, Sánchez-Valle R, Fortea J.

Alzheimers Dement. 2017 Nov;13(11):1251-1260. doi: 10.1016/j.jalz.2017.03.007. Epub 2017 Apr 29.

8.

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.

Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savaş DD, Engelborghs S, Grimmer T, Grosu G, Kramberger MG, Lawlor B, Mandic Stojmenovic G, Marinescu M, Mecocci P, Molinuevo JL, Morais R, Niemantsverdriet E, Nobili F, Ntovas K, O'Dwyer S, Paraskevas GP, Pelini L, Picco A, Salmon E, Santana I, Sotolongo-Grau O, Spiru L, Stefanova E, Popovic KS, Tsolaki M, Yener GG, Zekry D, Frisoni GB.

Alzheimers Dement. 2017 Sep;13(9):1013-1023. doi: 10.1016/j.jalz.2017.01.019. Epub 2017 Mar 3.

PMID:
28263741
9.

Altered Blood Gene Expression of Tumor-Related Genes (PRKCB, BECN1, and CDKN2A) in Alzheimer's Disease.

Antonell A, Lladó A, Sánchez-Valle R, Sanfeliu C, Casserras T, Rami L, Muñoz-García C, Dangla-Valls A, Balasa M, Boya P, Kalko SG, Molinuevo JL.

Mol Neurobiol. 2016 Nov;53(9):5902-5911. doi: 10.1007/s12035-015-9483-9. Epub 2015 Oct 28.

10.

CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.

Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.

Mol Neurobiol. 2017 Nov;54(9):6647-6654. doi: 10.1007/s12035-016-0106-x. Epub 2016 Oct 13.

PMID:
27738874
11.

Neurofilament light chain: a biomarker for genetic frontotemporal dementia.

Meeter LH, Dopper EG, Jiskoot LC, Sanchez-Valle R, Graff C, Benussi L, Ghidoni R, Pijnenburg YA, Borroni B, Galimberti D, Laforce RJ, Masellis M, Vandenberghe R, Ber IL, Otto M, van Minkelen R, Papma JM, Rombouts SA, Balasa M, Öijerstedt L, Jelic V, Dick KM, Cash DM, Harding SR, Jorge Cardoso M, Ourselin S, Rossor MN, Padovani A, Scarpini E, Fenoglio C, Tartaglia MC, Lamari F, Barro C, Kuhle J, Rohrer JD, Teunissen CE, van Swieten JC.

Ann Clin Transl Neurol. 2016 Jul 1;3(8):623-36. doi: 10.1002/acn3.325. eCollection 2016 Aug.

12.

White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.

Sánchez-Valle R, Monté GC, Sala-Llonch R, Bosch B, Fortea J, Lladó A, Antonell A, Balasa M, Bargalló N, Molinuevo JL.

J Alzheimers Dis. 2016;51(3):827-35. doi: 10.3233/JAD-150899.

13.

Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.

Sierra-Rio A, Balasa M, Olives J, Antonell A, Iranzo A, Castellví M, Bosch B, Grau-Rivera O, Fernandez-Villullas G, Rami L, Lladó A, Sánchez-Valle R, Molinuevo JL.

Neurodegener Dis. 2016;16(1-2):69-76. doi: 10.1159/000439258. Epub 2015 Nov 12.

PMID:
26560503
14.

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.

Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, Molinuevo JL, Stomrud E, Farotti L, Ramakers IHGB, Tsolaki M, Skarsgård C, Åstrand R, Wallin A, Vyhnalek M, Holmber-Clausen M, Forlenza OV, Ghezzi L, Ingelsson M, Hoff EI, Roks G, de Mendonça A, Papma JM, Izagirre A, Taga M, Struyfs H, Alcolea DA, Frölich L, Balasa M, Minthon L, Twisk JWR, Persson S, Zetterberg H, van der Flier WM, Teunissen CE, Scheltens P, Blennow K.

Alzheimers Dement. 2016 Feb;12(2):154-163. doi: 10.1016/j.jalz.2015.08.003. Epub 2015 Sep 11.

PMID:
26368321
15.

Evolving brain structural changes in PSEN1 mutation carriers.

Sala-Llonch R, Lladó A, Fortea J, Bosch B, Antonell A, Balasa M, Bargalló N, Bartrés-Faz D, Molinuevo JL, Sánchez-Valle R.

Neurobiol Aging. 2015 Mar;36(3):1261-70. doi: 10.1016/j.neurobiolaging.2014.12.022. Epub 2014 Dec 24.

PMID:
25638532
16.

Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort.

Balasa M, Gelpi E, Martín I, Antonell A, Rey MJ, Grau-Rivera O, Molinuevo JL, Sánchez-Valle R, Lladó A; Catalan collaborative Study Group for FTLD.

Neuropathol Appl Neurobiol. 2015 Dec;41(7):882-92. doi: 10.1111/nan.12194. Epub 2015 May 2.

PMID:
25381753
17.

Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.

Antonell A, Mansilla A, Rami L, Lladó A, Iranzo A, Olives J, Balasa M, Sánchez-Valle R, Molinuevo JL.

J Alzheimers Dis. 2014;42(3):901-8. doi: 10.3233/JAD-140624.

PMID:
25024322
18.

White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels.

Molinuevo JL, Ripolles P, Simó M, Lladó A, Olives J, Balasa M, Antonell A, Rodriguez-Fornells A, Rami L.

Neurobiol Aging. 2014 Dec;35(12):2671-2680. doi: 10.1016/j.neurobiolaging.2014.05.027. Epub 2014 Jun 6.

PMID:
25002037
19.

Large APP locus duplication in a sporadic case of cerebral haemorrhage.

Lladó A, Grau-Rivera O, Sánchez-Valle R, Balasa M, Obach V, Amaro S, Rey MJ, Molinuevo JL, Gelpi E, Antonell A.

Neurogenetics. 2014 May;15(2):145-9. doi: 10.1007/s10048-014-0395-z. Epub 2014 Apr 2.

PMID:
24691562
20.

Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.

Balasa M, Sánchez-Valle R, Antonell A, Bosch B, Olives J, Rami L, Castellví M, Molinuevo JL, Lladó A.

J Alzheimers Dis. 2014;40(4):919-27. doi: 10.3233/JAD-132195.

PMID:
24577466
21.

Clinical and neuropathological variability in clinically isolated central nervous system Whipple's disease.

Balasa M, Gelpi E, Rey MJ, Vila J, Ramió-Torrentà L, Quiles Granado AM, Molina Latorre R, Lepidi H, Raoult D, Saiz A.

Brain Pathol. 2014 Apr;24(3):230-8. doi: 10.1111/bpa.12113. Epub 2014 Jan 13.

PMID:
24320005
22.

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.

Alcolea D, Martínez-Lage P, Izagirre A, Clerigué M, Carmona-Iragui M, Alvarez RM, Fortea J, Balasa M, Morenas-Rodríguez E, Lladó A, Grau O, Blennow K, Lleó A, Molinuevo JL.

J Alzheimers Dis. 2014;39(4):719-26. doi: 10.3233/JAD-131334.

PMID:
24254700
23.

Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia.

Gil-Navarro S, Lomeña F, Cot A, Lladó A, Montagut N, Castellví M, Bosch B, Rami L, Antonell A, Balasa M, Pavia J, Iranzo A, Molinuevo JL, Sánchez-Valle R.

Eur J Neurol. 2013 Nov;20(11):1459-e126. doi: 10.1111/ene.12196. Epub 2013 May 17.

PMID:
23679075
24.

The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study.

Molinuevo JL, Gispert JD, Dubois B, Heneka MT, Lleo A, Engelborghs S, Pujol J, de Souza LC, Alcolea D, Jessen F, Sarazin M, Lamari F, Balasa M, Antonell A, Rami L.

J Alzheimers Dis. 2013;36(1):67-77. doi: 10.3233/JAD-130203.

PMID:
23524657
25.

Some clinical aspects in chronic autoimmune thyroiditis associated with thyroid differentiated cancer.

Zosin I, Golu I, Cornianu M, Vlad M, Balasa M.

Maedica (Buchar). 2012 Dec;7(4):277-83.

26.

Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.

Arenaza-Urquijo EM, Molinuevo JL, Sala-Llonch R, Solé-Padullés C, Balasa M, Bosch B, Olives J, Antonell A, Lladó A, Sánchez-Valle R, Rami L, Bartrés-Faz D.

J Alzheimers Dis. 2013;35(4):715-26. doi: 10.3233/JAD-121906.

PMID:
23481686
27.

A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease.

Antonell A, Lladó A, Altirriba J, Botta-Orfila T, Balasa M, Fernández M, Ferrer I, Sánchez-Valle R, Molinuevo JL.

Neurobiol Aging. 2013 Jul;34(7):1772-8. doi: 10.1016/j.neurobiolaging.2012.12.026. Epub 2013 Jan 28.

PMID:
23369545
28.

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.

Antonell A, Gil S, Sánchez-Valle R, Balasa M, Bosch B, Prat MC, Chiollaz AC, Fernández M, Yagüe J, Molinuevo JL, Lladó A.

J Alzheimers Dis. 2012;31(3):581-91. doi: 10.3233/JAD-2012-112120.

PMID:
22647257
29.

Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.

Rami L, Sala-Llonch R, Solé-Padullés C, Fortea J, Olives J, Lladó A, Peña-Gómez C, Balasa M, Bosch B, Antonell A, Sanchez-Valle R, Bartrés-Faz D, Molinuevo JL.

J Alzheimers Dis. 2012;31(3):517-26. doi: 10.3233/JAD-2012-120223.

PMID:
22596271
30.

[A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index].

Molinuevo JL, Gispert JD, Pujol J, Rojas S, Lladó A, Balasa M, Antonell A, Sánchez-Valle R, Rami L.

Rev Neurol. 2012 May 1;54(9):513-22. Spanish.

31.

PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.

Balasa M, Vidal-Piñeiro D, Lladó A, Antonell A, Bosch B, Castellanos F, Bargalló N, Bartres-Faz D, Molinuevo JL, Sánchez-Valle R.

J Alzheimers Dis. 2012;30(3):605-16. doi: 10.3233/JAD-2012-111949.

PMID:
22426017
32.

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease.

Balasa M, Gelpi E, Antonell A, Rey MJ, Sánchez-Valle R, Molinuevo JL, Lladó A; Neurological Tissue Bank/University of Barcelona/Hospital Clínic NTB/UB/HC Collaborative Group.

Neurology. 2011 May 17;76(20):1720-5. doi: 10.1212/WNL.0b013e31821a44dd.

PMID:
21576687
33.

A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.

Antonell A, Balasa M, Oliva R, Lladó A, Bosch B, Fabregat N, Fortea J, Molinuevo JL, Sánchez-Valle R.

Neurosci Lett. 2011 May 27;496(1):40-2. doi: 10.1016/j.neulet.2011.03.084. Epub 2011 Apr 9.

PMID:
21501661
34.

Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints.

Antonell A, Fortea J, Rami L, Bosch B, Balasa M, Sánchez-Valle R, Iranzo A, Molinuevo JL, Lladó A.

J Neural Transm (Vienna). 2011 Feb;118(2):259-62. doi: 10.1007/s00702-010-0534-0. Epub 2010 Dec 16.

PMID:
21161712

Supplemental Content

Loading ...
Support Center